These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 8243308)
1. The growth hormone (GH)-binding protein cloned from human IM-9 lymphocytes modulates the down-regulation of GH receptors by 22- and 20-kilodalton human GH in IM-9 lymphocytes and the biological effects of the hormone in Nb2 lymphoma cells. Hansen BS; Hjorth S; Welinder BS; Skriver L; De Meyts P Endocrinology; 1993 Dec; 133(6):2809-17. PubMed ID: 8243308 [TBL] [Abstract][Full Text] [Related]
2. N-terminal-truncated recombinant analogs of bovine placental lactogen: interaction with human and rat growth hormone receptors and insulin-like growth factor-I secretion mediated by somatogenic receptors in rat hepatocytes. Vashdi-Elberg D; Staten NR; Sakal E; Krivi GG; Gertler A Endocrinology; 1995 Mar; 136(3):1258-66. PubMed ID: 7867580 [TBL] [Abstract][Full Text] [Related]
3. Comparative study of in vitro and in vivo modulation of lactogenic and somatotropic receptors by native human growth hormone and its modified analog prepared by recombinant deoxyribonucleic acid technology. Ashkenazi A; Vogel T; Barash I; Hadari D; Levanon A; Gorecki M; Gertler A Endocrinology; 1987 Jul; 121(1):414-9. PubMed ID: 3595523 [TBL] [Abstract][Full Text] [Related]
4. Regulation of growth hormone (GH) bioactivity by a recombinant human GH-binding protein. Lim L; Spencer SA; McKay P; Waters MJ Endocrinology; 1990 Sep; 127(3):1287-91. PubMed ID: 2387255 [TBL] [Abstract][Full Text] [Related]
5. Human growth hormone fragments 1-43 and 44-191: in vitro somatogenic activity and receptor binding characteristics in human and nonprimate systems. Rowlinson SW; Waters MJ; Lewis UJ; Barnard R Endocrinology; 1996 Jan; 137(1):90-5. PubMed ID: 8536647 [TBL] [Abstract][Full Text] [Related]
6. Comparison between the human serum growth hormone-binding protein and the water-soluble growth hormone-binding site released from IM-9 lymphocytes. Massa G; Ilondo M; Vanderschueren-Lodeweyckx M Acta Endocrinol (Copenh); 1993 Dec; 129(6):559-64. PubMed ID: 8109191 [TBL] [Abstract][Full Text] [Related]
7. Reduction of lactogenic receptors in female hamster liver due to the human growth hormone analog produced by plerocercoids of the tapeworm, Spirometra mansonoides. Phares CK; Booth BJ Endocrinology; 1986 Mar; 118(3):1102-9. PubMed ID: 3004894 [TBL] [Abstract][Full Text] [Related]
8. Indication of different lactogen and somatogen binding sites in the human growth hormone molecule as probed with monoclonal antibodies. Strasburger CJ; Binder L; Elberg G; Cohen-Chapnik N; Kohen F; Gertler A Mol Cell Endocrinol; 1989 Nov; 67(1):55-62. PubMed ID: 2482210 [TBL] [Abstract][Full Text] [Related]
9. Growth hormone (GH) binding protein and GH interactions in vivo in the guinea pig. Fairhall KM; Carmignac DF; Robinson IC Endocrinology; 1992 Oct; 131(4):1963-9. PubMed ID: 1396340 [TBL] [Abstract][Full Text] [Related]
10. Chimeric bovine-human growth hormone prepared by recombinant DNA technology: binding properties and biological activity. Binder L; Vogel T; Hadary D; Elberg G; Gertler A Mol Endocrinol; 1989 Jun; 3(6):923-30. PubMed ID: 2739655 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of hypertonic sucrose and intracellular potassium depletion on growth hormone receptor binding kinetics and down-regulation in IM-9 cells: evidence for a sequential block of receptor--mediated endocytosis. Ilondo MM; Smal J; de Meyts P; Courtoy PJ Endocrinology; 1991 Mar; 128(3):1597-602. PubMed ID: 1999174 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of lactogenic activities of ovine prolactin and human growth hormone (hGH) by a novel form of a modified recombinant hGH. Gertler A; Shamay A; Cohen N; Ashkenazi A; Friesen HG; Levanon A; Gorecki M; Aviv H; Hadary D; Vogel T Endocrinology; 1986 Feb; 118(2):720-6. PubMed ID: 2417826 [TBL] [Abstract][Full Text] [Related]
14. A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein. Ross RJ; Esposito N; Shen XY; Von Laue S; Chew SL; Dobson PR; Postel-Vinay MC; Finidori J Mol Endocrinol; 1997 Mar; 11(3):265-73. PubMed ID: 9058373 [TBL] [Abstract][Full Text] [Related]
15. Site-directed mutagenesis of recombinant bovine placental lactogen at lysine-73 leads to selective attenuation of its somatogenic activity. Helman D; Staten NR; Byatt J; Grosclaude J; McKinnie RE; Djiane J; Gertler A Endocrinology; 1997 Oct; 138(10):4069-80. PubMed ID: 9322914 [TBL] [Abstract][Full Text] [Related]
16. Human IM-9 lymphoblasts as a model of the growth hormone-insulin-like growth factor axis: gene expression, and interactions of ligands with receptors and binding proteins. Yang Y; Hoeflich A; Kessler U; Barenton B; Blum W; Schwarz HP; Kiess W Regul Pept; 1993 Oct; 48(1-2):41-53. PubMed ID: 8265816 [TBL] [Abstract][Full Text] [Related]
17. The human placental growth hormone variant is mitogenic for rat lymphoma Nb2 cells. Nickel BE; Kardami E; Cattini PA Endocrinology; 1990 Feb; 126(2):971-6. PubMed ID: 2298178 [TBL] [Abstract][Full Text] [Related]
18. Receptor dimerization determines the effects of growth hormone in primary rat adipocytes and cultured human IM-9 lymphocytes. Ilondo MM; Damholt AB; Cunningham BA; Wells JA; De Meyts P; Shymko RM Endocrinology; 1994 Jun; 134(6):2397-403. PubMed ID: 8194466 [TBL] [Abstract][Full Text] [Related]
19. Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone. Silva CM; Lu H; Day RN Mol Endocrinol; 1996 May; 10(5):508-18. PubMed ID: 8732682 [TBL] [Abstract][Full Text] [Related]
20. The growth hormone-like factor produced by the tapeworm Spirometra mansonoides specifically binds receptors on cultured human lymphocytes. Phares CK; Watts DJ J Parasitol; 1988 Oct; 74(5):896-8. PubMed ID: 3418464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]